Volume 25 - Issue 2 - February 2017
03/21/2017
A dermal filler was recently approved for injection into facial tissue, in adults 21 years of age and older, for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.
A dermal filler was recently approved for injection into facial tissue, in adults 21 years of age and older, for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.
A dermal filler was recently...
03/21/2017
The Dermatologist
03/17/2017
A recent study comparing doxycycline and prednisolone found patients with bullous pemphigoid who received doxycycline as initial treatment achieved short-term blister control.
A recent study comparing doxycycline and prednisolone found patients with bullous pemphigoid who received doxycycline as initial treatment achieved short-term blister control.
A recent study comparing...
03/17/2017
The Dermatologist
03/15/2017
According to the findings from a recent open label phase 2 study of bertilimumab for bullous pemphigoid, Immune Pharmaceuticals will expand its enrollment eligibility criteria to include steroid tapering resistant patients.
According to the findings from a recent open label phase 2 study of bertilimumab for bullous pemphigoid, Immune Pharmaceuticals will expand its enrollment eligibility criteria to include steroid tapering resistant patients.
According to the findings from a...
03/15/2017
The Dermatologist
03/13/2017
Recent researcher suggests that approximately three-quarters of dermatology residents feel they are not adequately protected from carcinogens and infectious diseases in surgical smoke.
Recent researcher suggests that approximately three-quarters of dermatology residents feel they are not adequately protected from carcinogens and infectious diseases in surgical smoke.
Recent researcher suggests that...
03/13/2017
The Dermatologist
03/09/2017
The La Roche-Posay North American Foundation’s recently announced its 2017 research grant recipients and the 5th annual winner of the Dermatologist from the Heart program.
The La Roche-Posay North American Foundation’s recently announced its 2017 research grant recipients and the 5th annual winner of the Dermatologist from the Heart program.
The La Roche-Posay North...
03/09/2017
The Dermatologist
03/07/2017
Recent data presented at the American Academy of Dermatology Annual Meeting showed that the topical diacerein 1% in the treatment of epidermolysis bullosa simplex (EBS) demonstrated sustainable long-term benefit in reduction of blister...
Recent data presented at the American Academy of Dermatology Annual Meeting showed that the topical diacerein 1% in the treatment of epidermolysis bullosa simplex (EBS) demonstrated sustainable long-term benefit in reduction of blister...
Recent data presented at the...
03/07/2017
The Dermatologist
03/04/2017
Carpe Lotion is a new OTC skin-care preparation for individuals experiencing sweaty hands and feet.
Carpe Lotion is a new OTC skin-care preparation for individuals experiencing sweaty hands and feet.
Carpe Lotion is a new OTC...
03/04/2017
The Dermatologist
03/03/2017
Rochelle Nataloni
Dr Gelfand discusses the evolving landscape of psoriasis research and a multidisciplinary perspective to treating patients who present with inflammatory conditions in multiple organ systems.
Dr Gelfand discusses the evolving landscape of psoriasis research and a multidisciplinary perspective to treating patients who present with inflammatory conditions in multiple organ systems.
Dr Gelfand discusses the...
03/03/2017
The Dermatologist
Research in Review
02/28/2017
Michael H. Gold, MD, FAAD
Fractional radiofrequency with either pins or microneedles has become an important modality for improving wrinkles and rhytids, textural abnormalities, and acne and traumatic scars.
Fractional radiofrequency with either pins or microneedles has become an important modality for improving wrinkles and rhytids, textural abnormalities, and acne and traumatic scars.
Fractional radiofrequency with...
02/28/2017
The Dermatologist
02/27/2017
Combination noninvasive therapies were the biggest trend last year, according to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), annual survey.
Combination noninvasive therapies were the biggest trend last year, according to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), annual survey.
Combination noninvasive...
02/27/2017
The Dermatologist
Research in Review
02/26/2017
Lisa B. Samalonis
Dermatologists can point their patients with eczema to a variety of resources for support.
Dermatologists can point their patients with eczema to a variety of resources for support.
Dermatologists can point their...
02/26/2017
The Dermatologist
02/22/2017
This case of cutaneous mastocytosis includes features of telangiectasia macularis eruptiva perstans.
This case of cutaneous mastocytosis includes features of telangiectasia macularis eruptiva perstans.
This case of cutaneous...
02/22/2017
The Dermatologist
Derm Dx
02/17/2017
Zeynep Betül Erdem, MD; Emek Kocatürk, MD; Hatice Duman, MD; Ömer Özdemir, MD; Sinem Ayşe Örnek, MD
In this case, an otherwise healthy 43-year-old man presented with newly developed lesions on the plantar surface of the left foot.
In this case, an otherwise healthy 43-year-old man presented with newly developed lesions on the plantar surface of the left foot.
In this case, an otherwise...
02/17/2017
The Dermatologist
Research in Review
02/17/2017
John E. Wolf, Jr., MD, MA
Rosacea is a common chronic cutaneous disorder of the central face. In addition to its physical discomfort, patients report a negative impact on quality of life socially, professionally, and emotionally because of its conspicuous impact on...
Rosacea is a common chronic cutaneous disorder of the central face. In addition to its physical discomfort, patients report a negative impact on quality of life socially, professionally, and emotionally because of its conspicuous impact on...
Rosacea is a common chronic...
02/17/2017
The Dermatologist
Voices
02/17/2017
Navdeep Gosal; Jeffrey Fung
These families impacted by severe eczema were inspired to seek solutions.
These families impacted by severe eczema were inspired to seek solutions.
These families impacted by...
02/17/2017
The Dermatologist
Board Review
02/17/2017
Ron J. Feldman, MD, PhD; Jo-David Fine, MD, MPH, FRCP
The contents of these questions are taken from the Galderma Pre-Board Webinar.
The contents of these questions are taken from the Galderma Pre-Board Webinar.
The contents of these questions...
02/17/2017
The Dermatologist
Spotlight
02/16/2017
Benjamin Barankin, MD, FRCPC
Dirk Elston, MD, is professor and chairman of the department of dermatology and dermatologic surgery.
Dirk Elston, MD, is professor and chairman of the department of dermatology and dermatologic surgery.
Dirk Elston, MD, is professor...
02/16/2017
The Dermatologist
02/16/2017
The new dermatology spray or gel product Lasercyn from Oculus Innovative Sciences, Inc, is now available for use in the management of post-nonablative laser therapy procedures, postmicrodermabrasion therapy, and following superficial chemical...
The new dermatology spray or gel product Lasercyn from Oculus Innovative Sciences, Inc, is now available for use in the management of post-nonablative laser therapy procedures, postmicrodermabrasion therapy, and following superficial chemical...
The new dermatology spray or gel...
02/16/2017
The Dermatologist
Chief Medical Editor Message
02/16/2017
Steven R. Feldman, MD, PhD
The practice of medicine in general—and the practice of dermatology in particular—is changing rapidly (like everything else in the world).
The practice of medicine in general—and the practice of dermatology in particular—is changing rapidly (like everything else in the world).
The practice of medicine in...
02/16/2017
The Dermatologist
